Schaefer Thomas J.'s Form 4 filing
Arcadia Biosciences, Inc. (RKDA) · filed Aug 20, 2024
- Accession no.
- 0000950170-24-099335
- Filed
- Aug 20, 2024
- Trade date
- Aug 1, 2024
- Filing delay
- 19 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $1.44K. It was filed 19 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schaefer Thomas J.CIK 0001960808 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Common Stock | PPurchaseAcquired | +700 | $2.06 | +$1,442 | 2,119 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.